Cathie Wood Crispr Therapeutics Ag Call Options Transaction History
Ark Investment Management LLC
- $9.28 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Capital International Investors Los Angeles, CA6.07MShares$228 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$143 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$104 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$95.4 Million1.16% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$95.4 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.93B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....